| Followers | 22 |
| Posts | 2391 |
| Boards Moderated | 1 |
| Alias Born | 09/27/2020 |
Saturday, December 10, 2022 6:58:02 PM
The post referenced another post on 10/7/22 where an investor was adding shares in the $0.20 to $0.30 cent range.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170115116
On 10/10/22 IBIO implemented a 1-for-25 reverse split. While the prices in the $0.20 to $0.30 cent range might seem like a winner based on Friday's closing price of $0.6555 in after-hours trading, when one takes into account the impact of the reverse split, the shares purchased in that rage are at a HUGE LOSS in value.
Adjusting the closing price to the pre-RS value: $0.6555 / 25 = $0.02622
Calculating return of $0.20 shares: (0.20 - 0.02622)/0.20 * 100 = 86.9% LOSS
Calculating return of $0.30 shares: (0.30 - 0.02622)/0.30 * 100 = 91.3% LOSS
There are also posts by investors buying shares at $5.00.
Calculating return of $5.00 shares: (5.00 - 0.02622)/5.00 * 100 = 99.5% LOSS
OUCH!!! IBIO has been a TERRIBLE investment.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170115116
On 10/10/22 IBIO implemented a 1-for-25 reverse split. While the prices in the $0.20 to $0.30 cent range might seem like a winner based on Friday's closing price of $0.6555 in after-hours trading, when one takes into account the impact of the reverse split, the shares purchased in that rage are at a HUGE LOSS in value.
Adjusting the closing price to the pre-RS value: $0.6555 / 25 = $0.02622
Calculating return of $0.20 shares: (0.20 - 0.02622)/0.20 * 100 = 86.9% LOSS
Calculating return of $0.30 shares: (0.30 - 0.02622)/0.30 * 100 = 91.3% LOSS
There are also posts by investors buying shares at $5.00.
Calculating return of $5.00 shares: (5.00 - 0.02622)/5.00 * 100 = 99.5% LOSS
OUCH!!! IBIO has been a TERRIBLE investment.
Recent IBIO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/08/2026 01:00:47 PM
- iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia • GlobeNewswire Inc. • 04/08/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/27/2026 08:05:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:31:15 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 11:30:09 AM
- iBio to Provide an Update on Cardiopulmonary Program Targeting Pulmonary Hypertension Associated with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) • GlobeNewswire Inc. • 03/16/2026 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:04:38 AM
- iBio Reports Preclinical Body Composition Data from Obese Non-Human Primates Treated with IBIO-610, a Potential First-in-Class Treatment for Fat-Selective Weight Loss • GlobeNewswire Inc. • 03/09/2026 11:00:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/09/2026 04:15:16 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/06/2026 10:25:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2026 09:49:58 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/27/2026 09:23:59 PM
- iBio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/24/2026 12:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 11:19:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/10/2026 09:16:39 PM
- iBio Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/10/2026 09:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/09/2026 10:29:54 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/30/2026 09:10:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 11:15:07 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 01/30/2026 02:29:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 10:29:45 PM

